UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 2, 2012
 
MEDTOX SCIENTIFIC, INC.
  (Exact name of registrant as specified in its charter)
 
         
Delaware
 
1-11394
 
95-3863205
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
 
     
402 West County Road D, St. Paul, Minnesota
 
55112
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (651) 636-7466
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 1.01.                      Entry into a Material Definitive Agreement
 
On July 2, 2012, MEDTOX Laboratories, Inc., a wholly owned subsidiary of MEDTOX Scientific, Inc. (the "Company"), entered into a Second Amendment of Lease (“Second Amendment”) to the Commercial Lease ("Commercial Lease") dated July 28, 2000 and as amended on May 25, 2007, with St. Paul Properties, Inc. (“Lessor”).  The Second Amendment, effective as of August 31, 2012, extends the term of the lease to August 31, 2013 and provides for annual base rent rate of $154,500 per year for the period ending August 31, 2013.  The Amendment is filed herewith as Exhibit 10.1 and is incorporated herein by reference.


Item 9.01.                      Financial Statements and Exhibits .
 
 
(c)
Exhibits .
 
The following exhibit is filed as part of this report:
 
     
Exhibit No.
 
Description
10.1
 
Amendment of Lease dated July 2, 2012
     
     



 
- 2-
 


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


MEDTOX Scientific, Inc.




Date:  July 2, 2012                                                                                By:         /s/ Richard J. Braun                           
Name:  Richard J. Braun
Title:    Chief Executive Officer


 
- 3-
 

INDEX TO EXHIBITS

 
     
Exhibit No.
 
Description
10.1
 
Amendment of Lease dated July 2, 2012
     
     


- 4 -
Medtox Scientific, Inc. (MM) (NASDAQ:MTOX)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Medtox Scientific, Inc. (MM)
Medtox Scientific, Inc. (MM) (NASDAQ:MTOX)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Medtox Scientific, Inc. (MM)